Abstract
In our analysis, patients who were treated with intravenous rt-PA had a better outcome than untreated patients, and this effect was not dependent on age. The weight of evidence to date indicates a potential for benefit in older people, and there is no a priori reason to suspect a diminished effect when compared with younger people. The risk of bleeding is similar in both groups. We believe that clinical treatment guidelines should be revised in order to remove the age restriction in the use of intravenous rt-PA acute ischemic stroke.
Keywords: NINDS rt-PA, INTRACRANIAL BLEEDING, octogenarians, rt-PA, elderly, thrombolysis, Acute ischemic stroke
Cardiovascular & Hematological Disorders-Drug Targets
Title: Acute Management in Very Old Patients: Is Thrombolysis Safe?
Volume: 11 Issue: 1
Author(s): Fabiana Ortega and Maria C. Zurru
Affiliation:
Keywords: NINDS rt-PA, INTRACRANIAL BLEEDING, octogenarians, rt-PA, elderly, thrombolysis, Acute ischemic stroke
Abstract: In our analysis, patients who were treated with intravenous rt-PA had a better outcome than untreated patients, and this effect was not dependent on age. The weight of evidence to date indicates a potential for benefit in older people, and there is no a priori reason to suspect a diminished effect when compared with younger people. The risk of bleeding is similar in both groups. We believe that clinical treatment guidelines should be revised in order to remove the age restriction in the use of intravenous rt-PA acute ischemic stroke.
Export Options
About this article
Cite this article as:
Ortega Fabiana and C. Zurru Maria, Acute Management in Very Old Patients: Is Thrombolysis Safe?, Cardiovascular & Hematological Disorders-Drug Targets 2011; 11 (1) . https://dx.doi.org/10.2174/187152911795945204
DOI https://dx.doi.org/10.2174/187152911795945204 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface: Developments in Understanding of Alzheimer Disease
Current Alzheimer Research Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects
CNS & Neurological Disorders - Drug Targets Social Functioning Across the Course of Schizophrenia
Current Psychiatry Reviews Therapy Against Ischemic Injury
Current Pharmaceutical Design Recent Knowledge on Medicinal Plants as Source of Cholinesterase Inhibitors for the Treatment of Dementia
Mini-Reviews in Medicinal Chemistry Does an Interdisciplinary Network Improve Dementia Care? Results from the IDemUck-Study
Current Alzheimer Research Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
Current Alzheimer Research The Alzheimer's Disease-Related Glucose Metabolic Brain Pattern
Current Alzheimer Research Facial Pain Expression in Dementia: A Review of the Experimental and Clinical Evidence
Current Alzheimer Research Cerebrovascular Pathology and Responsiveness to Treatment in Alzheimer’s Disease: A Systematic Review
Current Alzheimer Research Imaging of Glucose Uptake During Walking in Elderly Adults
Current Aging Science Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases
Current Drug Therapy The Over-Under on the Misdiagnosis of Bipolar Disorder: A Systematic Review
Current Psychiatry Reviews Fructose 1,6-Bisphosphate: A Summary of Its Cytoprotective Mechanism
Current Medicinal Chemistry Neurotrophic Factors in Combination: A Possible new Therapeutic Strategy to Influence Pathophysiology of Spinal Cord Injury and Repair Mechanisms
Current Pharmaceutical Design Technological Solutions for Older People with Alzheimer’s Disease: Review
Current Alzheimer Research Ameliorative Effect of Phosphodiesterase-5 Inhibitor in Rat Model of Vascular Dementia
Current Neurovascular Research Ischemia-Reperfusion Injury of the Cochlea: Pharmacological Strategies for Cochlear Protection and Implications of Glutamate and Reactive Oxygen Species
Current Neuropharmacology Editorial [ Hot Topic: Anti Alzheimer Agents (Guest Editor: Helmut Hugel)]
Mini-Reviews in Medicinal Chemistry